ARTICLE | Company News
Zenapax gets pediatric indication
July 5, 2002 7:00 AM UTC
Protein Design Labs (PDLI) partner Roche (SWX:ROCZ) received EMEA approval for Zenapax daclizumab to prolong kidney graft survival in children with end-stage renal disease. ROCZ already markets the pr...